The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Levbid
hyoscyamine sulfate · HYOSCYAMINE SULFATE .375 mg/1 · Tablet, Extended Release · Oral · Viatris Specialty LLC
NDC 68220-0115-10 · 1 TABLET, EXTENDED RELEASE in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$505.13
Reported to Texas DSHS · 2026 annual filing · Viatris Specialty LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for hyoscyamine sulfate (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of hyoscyamine sulfate (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| ANI Pharmaceuticals, Inc. | HYOSCYAMINE SULFATE .375 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | HYOSCYAMINE SULFATE .375 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Laser Pharmaceuticals, LLC | HYOSCYAMINE SULFATE .375 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | HYOSCYAMINE SULFATE .375 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patrin Pharma, Inc. | HYOSCYAMINE SULFATE .375 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Viatris Specialty LLC | HYOSCYAMINE SULFATE .375 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Pharma Packaging Solutions, LLC dba Tjopack LLC | HYOSCYAMINE SULFATE .375 mg/1 | Jul 15, 2026 | Jul 22, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Levbid — NDC 68220-0115-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68220011510.
Free to cite with attribution — see how the data is put together.